Abstract
Aim
This study analyzes a number of diabetic mastopathy cases in long-standing type 1 diabetes to obtain a detailed history and examination findings from these patients and to reach a possible conclusion of arriving at the diagnosis.
Subjects and methods
A 10-year retrospective study was done from January 2008 to December 2018 on patients who attended the diabetic outpatient department diagnosed for type 1 diabetes mellitus and presented with breast complaints. Complete history and examination of all these patients were noted. The collected data were analyzed with IBM SPSS Statistics software version 16.0.
Results
All of the patients had a similar presentation and had undergone excision biopsy of the lump. Histopathology examination reports have confirmed a diagnosis of diabetic mastopathy. The clinical and imaging findings are inconclusive and these lesions are often misdiagnosed as breast carcinomas.
Conclusion
The recognition of this rare but benign disease is crucial to avoid surgical biopsies, which are performed more often than necessary.
Similar content being viewed by others
References
Akahori H, Kaneko M, Kiyohara K, Terahata S, Sugimoto T (2009) A rare case of diabetic mastopathy in a Japanese man with type 2 diabetes mellitus. Intern Med 48:915–919
Barr RG, Zhang Z (2012) Effects of precompression on elasticity imaging of the breast: development of a clinically useful semiquantitative method of precompression assessment. J Ultrasound Med 31:895–902
Campos GC, Castro MV, de Mattos VF, Pinto LZ, Boechat MC, Dos Santos AA (2014) Lymphocytic mastopathy mimicking breast malignancy: a case report. Radiol Bras 47:256–258
Christiaensen E, Jacquemyn Y, Verslegers I, Van Goethem M, Van Marck V (2009) Axillary lymphadenopathy as a first symptom of diabetic mastopathy. BMJ Case Rep 2009;bcr03.2009.1703
Honda M, Mori Y, Nishi T, Mizuguchi K, Ishibashi M (2007) Diabetic mastopathy of bilateral breasts in an elderly Japanese woman with type 2 diabetes: a case report and a review of the literature in Japan. Intern Med 46:1573–1576
Isomoto I, Wada T, Abe K, Uetani M (2009) Diagnostic utility of diffusion-weighted magnetic resonance imaging in diabetic mastopathy. Clin Imaging 33:146–149
Kim J, Kim EK, Kim MJ, Moon HJ, Yoon JH (2016) Diabetic mastopathy: imaging features and the role of image-guided biopsy in its diagnosis. Ultrasonography 35:140–147
Kirby RX, Mitchell DI, Williams NP, Cornwall DA, Cawich SO (2013) Diabetic mastopathy: an uncommon complication of diabetes mellitus. Case Rep Surg 2013:198502
Kudva YC, Reynolds C, O’Brien T, Powell C, Oberg AL, Crotty TB (2002) “Diabetic mastopathy,” or sclerosing lymphocytic lobulitis, is strongly associated with type 1 diabetes. Diabetes Care 25:121–126
Membrilla E, Jimeno M, Martínez M, Maria Corominas J, Solsona J, Grande L (2009) Diabetic mastopathy in diabetes mellitus type 2. Endocrinol Nutr 56:43–46
Miura K, Teruya C, Hatsuko N, Ogura H (2012) Autoantibody with cross-reactivity between insulin and ductal cells may cause diabetic mastopathy: a case study. Case Rep Med 2012:569040
Neetu G, Pathmanathan R, Weng NK (2010) Diabetic mastopathy: a case report and literature review. Case Rep Oncol 3:245–251
Sankaye S, Kachewar S (2012) Diabetic mastopathy. Australas Med J 5:296–299
Soler NG, Khardori R (1984) Fibrous disease of the breast, thyroiditis, and cheiroarthropathy in type I diabetes mellitus. Lancet 1:193–195
Thanarajasingam U, Chen B, Tortorelli CL, Jakub JW, Ghosh K (2011) Diabetic mastopathy as a radiographically occult palpable breast mass. Case Rep Med 2011:162350
Acknowledgements
The authors acknowledge the support and help provided by Sri Ramachandra Institute of Higher Education and Research, Chennai, India (IEC/PG/16/Dec/07/44).
This article has not been submitted, published, or presented previously to any journal. The results of a pilot study (not a completed research work) were presented in conference proceedings as an abstract.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Informed consent
As per the institutional review board, this study did not require any informed consent from patients directly. The institutional review board approved the study and data were collected retrospectively from a clinical database.
Human rights
The study “A breast lump that scares a doctor and the patient equally: unexpected and complicated surgical consequences of long-standing diabetes” was conducted in agreement with the institutional ethical review board of Sri Ramachandra Institute of Higher Education and Research, Chennai, India (CSP/17/June/49/2017). This study did not require informed consent from patients.
Sample statement
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and/or with the Helsinki Declaration of 1964 and later versions. Informed consent or substitute was not required to be obtained from patients included in the study.
Conflict of interest
The authors do not have anything to disclose and declare no conflict of interest.
Financial support and sponsorship
No financial support was obtained for this research.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Iyyappan, R.P., Vasudevan, A., Bhuvaneswari, T.H. et al. A breast lump that scares a doctor and the patient equally: unexpected and complicated surgical consequences of long-standing diabetes. J Public Health (Berl.) 29, 509–513 (2021). https://doi.org/10.1007/s10389-019-01162-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10389-019-01162-5